The global pharmaceutical unit dose packaging market is expected to attain an impressive valuation of USD 34.2 billion in 2023 and is projected to reach USD 136 billion by 2033, expanding at a CAGR of 14.8%.
The thriving growth in pharmaceutical sector is one of the primary growth determinants for inducing pharmaceutical unit dose packaging sales. The pharmaceutical business has been expanding at a rapid pace in recent years due to technological and scientific advancements. This trend is predicted to continue over the forecast period which will positively influence product demand.
The rising desire to decrease drug wastage is further proliferating product sales. Medication waste has a substantial financial impact on the healthcare system which creates negative environmental consequences. For this purpose, adoption of unit dose packaging becomes necessary, which is expected to fuel growth in the market.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | USD 34.2 billion |
| Anticipated Forecast Value (2033) | USD 136 billion |
| Projected Growth Rate (2023 to 2033) | CAGR 14.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for pharmaceutical unit dose packaging was worth USD 17.2 billion in 2018. It accumulated a market value of USD 30 billion in 2022 while growing at a CAGR of 14.9% from 2018 to 2022.
With the advent of new and biosimilar therapies for viral disorders, cancer, and other debilitating diseases, the demand for unit-dose pre-fillable syringes and parental vials is expected to rise in the coming years.
Increasing patient compliance through packaging designs is a major trend supporting market growth. This will promote the use of strip and blister packs, as well as other unit-dose containers. Clinical drug trials are also expected to generate growth opportunities for unit-dose packaging systems that promote compliance and recordkeeping.
Ongoing improvements in syringe design and safety are facilitating therapies meant for self-injection. This is estimated to propel demand for unit-dose parenteral vials and pre-fillable syringes. An increasing focus on infection prevention in parenteral drug delivery systems used in clinics, hospitals, physicians’ offices, and nursing homes will most likely fuel product demand in the next ten years.
Additionally, demand for unit-dose formats will rise in response to the growth of global preventive medicine, which requires single-dose injectable vaccines for diseases like COVID-19, meningitis, influenza, and shingles. After a comprehensive analysis of above-mentioned factors, the revenue growth of pharmaceutical unit dose packaging devices market is projected to be worth USD 136 billion by end of the forecast period, while exhibiting a CAGR of 14.8%.
Introduction of new injectable parenteral therapies to drive the market growth
The expanding healthcare system, increasing per capita income, and heavy investments in drug development are some of the key factors driving the market growth. The growing importance of generic drugs and access to better healthcare services is further expected to boost product sales.
For instance, the 21st Century Cures Act (Cures Act) came into effect on December 13, 2016, in the United States. It is designed to fasten medical product development. The law is expected to generate new innovations in product developments in the pharmaceutical industry. It is estimated to drive the demand for unit dose packaging in the forthcoming years.
Advancements in biotechnology are further expected to drive the growth of primary pharmaceutical packaging like unit dose packaging, resulting in the launch of new injectable parenteral therapies. Moreover, surging demand for high-visibility unit dosage packaging for diseases like diabetes is anticipated to fuel market expansion.
Along with this, the pharmaceutical secondary packaging industry is reflecting significant growth. Due to this, the growth is driven by factors such as rising use of unit dose packaging for drugs, increasing importance of product safety and traceability, and surge in use of child-resistant and senior-friendly packaging.
With the rising use of unit dose packaging for drugs, there is an increased adoption trend of pharmaceutical secondary packaging solutions that can guarantee accurate dosage and minimize the risk of medication errors.
Principal Consultant
High cost of packaging to restrain market expansion
The growth in the market is expected to be hampered by increasing overall packaging costs as a result of changing regulations and laws. The high installation cost of automated systems and their upkeep costs are further anticipated to hinder market growth.
North America to dominate the market with maximum share
North America dominated the market by accumulating a revenue share of 21.2% in 2022. The region is expected to retain this trend by accounting for over 38.6% market share by end of the forecast period.
The presence of several manufacturers of pharmaceutical plastic bottles in the country, including Gerresheimer AG, AptarGroup Inc., Amcor Ltd., and Berry Plastics Group, Inc., is likely to have a positive impact on the demand for single-dose pharmaceutical bottles.
The regional growth is further expected to grow due to thriving economies, a rising geriatric population, and advanced medical delivery systems.
Due to advanced primary medical community, rising research activities in life science and medical science, increasing healthcare spending intensity, and huge presence of pharmaceutical and medical supply and device industries in the region, the product demand is expected to rise.
The United States alone accounted for 11.90% of revenue share in 2022. It is expected to accumulate a 12.8% market share by end of 2023. The region is experiencing strong medication adherence in the correctional setting. The imprisoned population in most correctional facilities depends on outside pharmacies to fill their prescriptions.
Additionally, an onsite pharmacist may be provided in some instances, but such staff is generally restricted, depending on a central location to supply drugs and an onsite nurse manager or similar to dispense. This bolsters the case for dispensing administration systems like unit dose packaging that are low-effort for personnel while yet being able to ensure patient adherence.
China driving growth with significant CAGR
The market in China is expected to grow with a significant CAGR of 6.9% throughout the forecast period. Increasing health awareness among consumers in this region coupled with the inflating disposable income levels is expected to boost the growth of the pharmaceutical industry, thereby directly fuelling demand for unit-dose pharmaceutical packaging.
China dominated the Asia Pacific regional market in 2022 and is expected to retain this trend over the next ten years as well. Factors such as rising government initiatives, such as Healthy China 2020, increasing contract-manufacturing activities, and a burgeoning aging population are anticipated to propel growth in the region’s market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Vials driving market growth by accumulating maximum share
Vials accounted for a 25.2% share in 2022, on the basis of packaging type. This segment is expected to account for a dominating share by accumulating over 35% share by end of the forecast period. Primary packaging like vials comes in direct contact with the drug which envelopes the drug and prevents it from contamination.
Further, it is often employed for dispensing and dosing drug contents. Packaging companies are concentrating on easy-to-open closures and integration of dispensing systems that deliver the right dose at the right time, which can aid the geriatric population in drug dosage. This aspect is estimated to boost segment growth in the forthcoming period.
Plastic to rule the market with maximum share
Plastics & polymers registered a maximum revenue share of 47.5% in 2022. This segment is anticipated to account for 47.9% of revenue share in 2023. Plastic offers a combination of properties, like physical, mechanical, electrical, and thermal characteristics.
Drug formulations generally employ plastic material packaging because it provides safety, reduces breakage, and is easy to manufacture and design.
Compared to glass, Polyethylene maintains a strong protective structure, provides moisture resistance, and can provide weight reduction by up to 90%, making shipping more cost-friendly. The qualities of PET can be further improved using colorants, Oxygen barriers and scavengers, Ultraviolet filters, and other additives to create packaging customized to a particular brand’s needs.
Start-ups help in determining future growth opportunities in any market. These new entrants have the potential to generate high returns which directly benefits the expansion of any industry. These start-ups are typically more productive at transforming inputs into outputs with more flexibility and adaptability in nature, able to shift quickly in response to volatile market conditions. Some of the start-ups that will fuel the expansion of Pharmaceutical Unit Dose Packaging market are
The pharmaceutical unit dose packaging market is extremely competitive and consists of various key industry players. These players are heavily investing in manufacturing unit dose pharmaceutical packaging solutions.
The key industry players are: Gerresheimer AG, West Pharmaceuticals Services, Inc, Schott AG, SGD SA, Stevanato Group S.p.a., Klockner Pentaplast Group, UDG Healthcare plc., Amcor plc., Berry Global, Inc., Comar LLC, Constantia Flexibles Group GmbH, Nipro Corporation, Catalent Inc., Becton, Dickinson and Company, Adelphi Healthcare Packaging, Winpak Ltd., Pacific Vial Manufacturing Inc., Sonoco Products Company, WestRock Company, AptarGroup, Inc.
Some recent developments in the market are
Key market players are leveraging on inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to enhance their product portfolio. This is expected to fuel the global Pharmaceutical Unit Dose Packaging Market.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 34.2 billion |
| Market Value in 2033 | USD 136 billion |
| Growth Rate | CAGR of 14.8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Product, Material, End Use, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Singapore, Thailand, Indonesia, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Companies Profiled | Gerresheimer AG; West Pharmaceuticals Services, Inc.; Schott AG; SGD SA; Stevanato Group S.p.a.; Klockner Pentaplast Group; UDG Healthcare plc.; Amcor plc.; Berry Global, Inc.; Comar LLC; Constantia Flexibles Group GmbH; Nipro Corporation; Catalent Inc.; Becton, Dickinson and Company; Adelphi Healthcare Packaging; Winpak Ltd.; Pacific Vial Manufacturing Inc.; Sonoco Products Company; WestRock Company; AptarGroup, Inc. |
| Customization | Available Upon Request |
FMI projects the global pharmaceutical unit dose packaging market to expand at 14.8% value CAGR by 2033.
The global pharmaceutical unit dose packaging market is expected to garner a market value of USD 136 billion by 2033.
FMI has projected China to be one of the most attractive regions for pharmaceutical unit dose packaging market.
India is anticipated to grow at 7.9% CAGR throughout the forecast period.
Vials is expected to dominate the market by product type during the forecast period
Plastic is projected to lead the market with maximum share by end of the forecast period.
The market value of pharmaceutical unit dose packaging was worth USD 17.2 billion in 2018.
The market in North America is projected to account for 38.6 % market share by end of the forecast period.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Blisters 5.2. Ampoules 5.3. Vials 5.4. Prefilled Syringes Cartridges 6. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material 6.1. Plastic 6.1.1. Polyethylene 6.1.2. Polypropylene 6.1.3. Poly vinyl chloride 6.1.4. Polyethylene Terephthalate 6.2. Aluminium 6.3. Glass 6.4. Paper & Paperboard 7. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 7.1. Ophthalmic 7.2. Injectable 7.3. Biologics 7.4. Wound Care 7.5. Respiratory Therapy 7.6. Orals 8. Global Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. MEA 9. North America Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. MEA Pharmaceutical Unit Dose Packaging Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Pharmaceutical Unit Dose Packaging Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Gerresheimer AG 16.2. West Pharmaceutical Services, Inc. 16.3. Schott AG 16.4. Stevanato Group S.p.a. 16.5. Klockner Pentaplast Group 16.6. Amcor plc 16.7. Berry Global, Inc. 16.8. Constantia Flexibles Group GmbH 16.9. Nipro Corporation 16.10. Becton, Dickinson and Company 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Packaging Insights
View Reports
Pharmaceutical Unit Dose Packaging Market
